LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Lista de Ações・Medtronic PLC

Search

Medtronic PLC

Fechado

SetorSaúde

78.65 0.83

Visão Geral

Variação de preço das ações

24h

Atual

Mín

78.61

Máximo

78.91

Indicadores-chave
By Trading Economics
Rendimento	-231M 1.1B
Vendas	57M 9B
P/E Médio do Setor	21.598 49.701
EPS	0.89
Rendimento de Dividendos	3.72
Margem de lucro	12.675
Funcionários	95,000
EBITDA	124M 2.5B

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+33.44% upside

Dividendos
By Dow Jones
Rendimento de Dividendos Médio do Setor	3.72% 2.39%
Próximos Ganhos	3 de jun. de 2026
Próxima data de dividendos	10 de jul. de 2026
Próxima data de ex-dividendo	26 de jun. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-28B 99B
Abertura anterior	77.82
Fecho anterior	78.65

Sentimento de Notícias

By Acuity

42%

58%

127 / 345 Ranking em Healthcare

Medtronic PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

20 de mai. de 2026, 13:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic to Buy SPR Therapeutics for About $650 Million

10 de mar. de 2026, 11:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic to Buy Scientia Vascular in $550 Million Deal

17 de fev. de 2026, 12:43 UTC

Ganhos

Medtronic 3Q Profit Falls Despite Higher Revenue

20 de mai. de 2026, 13:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20 de mai. de 2026, 13:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22 de abr. de 2026, 11:27 UTC

Ganhos

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20 de abr. de 2026, 11:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24 de mar. de 2026, 20:59 UTC

Ganhos

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10 de mar. de 2026, 10:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10 de mar. de 2026, 10:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10 de mar. de 2026, 10:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10 de mar. de 2026, 10:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Medtronic to Acquire Scientia Vascular >MDT

17 de fev. de 2026, 21:21 UTC

Ganhos

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17 de fev. de 2026, 18:11 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 de fev. de 2026, 14:48 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 de fev. de 2026, 13:00 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 de fev. de 2026, 12:05 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 de fev. de 2026, 11:47 UTC

Ganhos

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17 de fev. de 2026, 11:47 UTC

Ganhos

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17 de fev. de 2026, 11:46 UTC

Ganhos

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17 de fev. de 2026, 11:46 UTC

Ganhos

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17 de fev. de 2026, 11:46 UTC

Ganhos

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Adj EPS $1.36 >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Sales $9.02B >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Diabetes Rev $796M >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17 de fev. de 2026, 11:45 UTC

Ganhos

Medtronic 3Q Net $1.14B >MDT

Comparação entre Pares

Variação de preço

Medtronic PLC Previsão

Preço-alvo

By TipRanks

33.44% parte superior

Previsão para 12 meses

Média 104.88 USD 33.44%

Máximo 120 USD

Mínimo 84 USD

Com base em 18 analistas de Wall Street que oferecem metas de preço de 12 meses para Medtronic PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

18 ratings

11

Comprar

7

Manter

0

Vender

Com base em 18 analistas que deram avaliações de ações para Medtronic PLC - Dist nos últimos 3 meses.

Sentimento

By Acuity

127 / 345 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Outras ações do setor

LLY

Eli Lilly and Co.

1,066.82

JNJ

Johnson and Johnson

234.57

ABBV

AbbVie Inc

216.12

UNH

UnitedHealth Group Inc

388.17

AZN

AstraZeneca PLC

187.25

Live chat